PTC Therapeutics, Inc. logo PTCT - PTC Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 16
HOLD 8
SELL 2
STRONG
SELL
0
| PRICE TARGET: $98.00 DETAILS
HIGH: $120.00
LOW: $82.00
MEDIAN: $94.00
CONSENSUS: $98.00
UPSIDE: 42.42%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue
Revenue 1,730.7 806.8 937.8 698.8 538.6 380.8 307.0 264.7 194.4 82.7 36.8 23.0 31.3 28.8 99.0
Cost of Revenue 71.8 57.4 65.5 44.7 32.3 18.9 12.1 12.7 4.6 117.6 121.8 79.8 54.9 (5.2) 0
Gross Profit 1,658.9 749.4 872.3 654.1 506.3 361.8 294.8 252.1 189.8 (34.9) (85.0) (56.9) (23.5) 33.9 99.0
Operating Expenses
R&D Expenses 455.2 534.5 666.6 651.5 540.7 477.6 257.5 172.0 117.5 117.6 121.8 79.8 54.9 46.1 58.7
SG&A Expenses 347.1 300.9 332.5 326.0 285.8 245.2 202.5 153.5 121.3 97.1 82.1 44.8 25.2 14.6 16.2
Other Expenses 0 216.6 312.7 124.0 54.3 70.8 76.0 0.1 (1.3) (1.2) (0.5) (0.2) 0.0 1.8 0.5
Operating Expenses 802.4 1,052.0 1,311.8 1,101.5 880.7 793.6 536.0 348.4 254.1 214.8 203.9 122.4 76.7 55.6 68.4
Operating Income
Operating Income 856.5 (302.6) (439.5) (447.4) (374.4) (431.8) (241.2) (115.7) (64.3) (132.1) (167.1) (99.4) (45.4) (26.8) 30.6
Interest Expense 152.2 167.0 129.2 90.9 86.0 56.4 12.5 12.6 12.1 8.3 2.4 1.2 6.1 1.2 2.4
Interest Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA 887.7 (120.5) (330.3) (367.8) (368.2) (303.1) (195.3) (89.5) (46.6) (128.8) (164.3) (97.2) (43.0) (24.1) 33.5
EBIT 848.8 (196.1) (566.9) (496.6) (432.3) (346.6) (227.4) (115.6) (64.3) (132.1) (167.1) (99.4) (45.4) (26.8) 30.6
Income Before Tax 696.6 (363.1) (696.1) (587.5) (518.3) (402.9) (239.9) (128.1) (77.7) (141.5) (170.0) (98.4) (51.6) (26.2) 28.6
Income Tax Expense 14.0 0.2 (69.5) (28.5) 5.6 35.2 11.7 (0.0) 1.3 0.6 0.5 (4.7) 6.2 1.2 (2.3)
Net Income 682.6 (363.3) (626.6) (559.0) (523.9) (438.2) (251.6) (128.1) (79) (142.1) (170.4) (93.8) (51.6) (26.2) 30.9
Per Share Data
EPS (Basic) 8.58 -4.73 -8.37 -7.79 -7.43 -6.64 -4.27 -2.75 -2.02 -4.17 -5.07 -2.97 -4.02 -1.85 0.00
EPS (Diluted) 7.78 -4.73 -8.37 -7.79 -7.43 -6.64 -4.27 -2.75 -2.02 -4.17 -5.07 -2.97 -4.02 -1.11 0.00
Shares Outstanding 79.5 76.8 74.8 71.7 70.5 66.0 58.9 46.6 39.1 34.0 33.6 31.6 12.8 14.2 14.2
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 984.6 779.7 594.0 279.8 189.7 208.8 288.0 227.6 191.2 231.7
Short-Term Investments 960.7 360.0 282.7 130.9 583.7 894.8 398.5 0 0 0
Net Receivables 181.6 158.6 160.8 155.6 110.5 69.9 55.5 67.9 40.4 24.9
Inventory 79.6 23.2 30.6 21.8 15.9 18.7 19.3 16.1 10.8 0
Other Current Assets 67.3 44.1 150.5 105.7 0 0 0 9.2 6.7 4.7
Total Current Assets 2,273.9 1,365.5 1,218.6 693.8 954.4 1,231.7 779.3 320.9 249.1 261.3
Non-Current Assets
Property, Plant & Equipment 135.4 117.7 179.0 175.0 130.0 118.2 35.2 12.7 8.4 7.4
Goodwill 82.3 82.3 82.3 82.3 82.3 82.3 82.3 82.3 0 0
Intangible Assets 388.8 118.8 379.5 705.9 724.8 715.3 710.5 701.0 133.0 0
Long-Term Investments 13.7 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 4.6 20.7 36.2 48.6 46.5 60.6 16.4 2.3 1.2 0.6
Total Non-Current Assets 637.3 339.5 677.1 1,011.8 983.7 976.5 844.5 798.4 142.6 8.1
Total Assets 2,911.2 1,705.0 1,895.7 1,705.6 1,938.1 2,208.3 1,623.8 1,119.2 391.7 269.3
Current Liabilities
Account Payables 45.5 17.3 6.0 27.3 23.0 18.7 10.3 6.0 15.3 6.3
Short-Term Debt 302.1 257.8 194.3 72.1 208.8 0 20 11.7 0 0
Deferred Revenue 2.0 5.5 0.8 1.4 0 4.2 8.2 3.7 3.9 1.6
Other Current Liabilities 540.4 120.2 139.8 126.5 118.9 129.9 120.2 117.8 45.1 29.7
Total Current Liabilities 968.4 581.0 603.1 406.2 509.3 277.3 235.9 166.8 82.0 49.6
Non-Current Liabilities
Long-Term Debt 93.6 2,109.4 1,904.0 1,257.5 956.6 309.1 293.9 141.3 145.0 98.2
Deferred Tax Liabilities 12.5 0 55.9 102.8 137.1 136.7 130.9 122.0 (3.9) 0
Other Non-Current Liabilities 1,945.5 22.2 36.4 166.6 239.9 900.5 356.4 328.6 0.2 0.3
Total Non-Current Liabilities 2,148.1 2,222.1 2,111.2 1,646.5 1,427.3 1,449.0 793.6 601.7 153.2 100.1
Total Liabilities 3,116.6 2,803.1 2,714.3 2,052.7 1,936.6 1,726.3 1,029.5 768.5 235.2 149.8
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0
Retained Earnings (2,964.2) (3,646.9) (3,283.6) (2,657.0) (2,098.0) (1,628.9) (1,190.5) (938.9) (814.1) (735.1)
Accumulated Other Comprehensive Income 10.5 (25.9) (1.3) 4.8 (24.3) (61.0) (10.6) 1.5 4.0 (1.5)
Total Stockholders' Equity (205.3) (1,098.1) (818.6) (347.1) 1.4 482.0 594.3 350.7 156.4 119.6
Total Liabilities & Equity 2,911.2 1,705.0 1,895.7 1,705.6 1,938.1 2,208.3 1,623.8 1,119.2 391.7 269.3
Debt Metrics
Total Debt 492.3 2,471.1 2,229.1 1,461.5 1,269.4 420.4 328.0 153.0 145.0 98.2
Net Debt (492.4) 1,691.4 1,635.1 1,181.7 1,079.6 211.6 40.0 (74.6) (46.3) (133.4)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 682.6 (363.3) (626.6) (559.0) (523.9) (438.2) (251.6) (128.1) (79) (142.1)
Depreciation & Amortization 38.8 75.7 236.6 128.8 64.1 84.9 32.2 26.1 17.7 3.3
Stock-Based Compensation 0 74.6 131.2 110.3 103.5 70.3 42.1 33.3 30.6 35.0
Change in Working Capital (52.6) 102.5 (4.0) (85.3) (23.8) 36.9 20.4 14.2 13.2 (9.0)
Other Non-Cash Items 42.3 58.7 151.3 82.8 128.3 46.1 49.4 27.4 7.3 9.4
Operating Cash Flow 711.2 (107.7) (158.4) (356.7) (251.3) (194.1) (98.6) (27.6) (10.1) (103.6)
Investing Activities
Capital Expenditure (8.9) (74.2) (120.6) (152.5) (85.3) (56.0) (45.4) (15.5) (3.1) (1.8)
Acquisitions 0.1 0 0 128.4 57.1 38.1 (4) (48.9) (77.2) 0
Purchases of Investments (1,417.2) (667.4) (212.5) (75.6) (543.3) (1,449.7) (494.1) (68.6) (81.4) (85.4)
Sales/Maturities of Investments 855.1 607.7 156.4 518.2 847.8 944.1 156.3 90.4 174.7 191.6
Other Investing Activities 0 110.3 (92.2) (128.4) (57.1) (38.1) 0 13.4 16.2 106.3
Investing Cash Flow (862.0) 44.2 (176.7) 290.2 219.2 (561.5) (387.2) (42.6) 13.1 104.5
Financing Activities
Net Debt Issuance 0 (1.5) (301.4) 148.7 (2.2) (46.2) 267.6 0 40 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 232.0 257.4 947.8 (30.8) 0 686.8 21.9 13.7 4.2 1.0
Financing Cash Flow 331.1 255.9 646.4 168.0 20.9 668.7 613.2 131.6 44.2 1.0
Cash Position
Net Change in Cash 204.9 185.0 314.4 98.7 (19.1) (79.2) 126.0 57.7 53.5 0.3
Cash at Beginning 779.7 610.3 295.9 197.2 216.3 295.5 169.5 111.8 58.3 58.0
Cash at End 984.6 795.3 610.3 295.9 197.2 216.3 295.5 169.5 111.8 58.3
Free Cash Flow 702.3 (181.9) (279.0) (509.1) (336.7) (250.0) (144.1) (43.2) (13.2) (105.3)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Income Statement
Revenue 1,730.7 806.8 937.8 698.8 538.6 380.8 307.0 264.7 194.4 82.7 36.8 23.0 31.3 28.8 99.0
Gross Profit 1,658.9 749.4 872.3 654.1 506.3 361.8 294.8 252.1 189.8 (34.9) (85.0) (56.9) (23.5) 33.9 99.0
Operating Income 856.5 (302.6) (439.5) (447.4) (374.4) (431.8) (241.2) (115.7) (64.3) (132.1) (167.1) (99.4) (45.4) (26.8) 30.6
Net Income 682.6 (363.3) (626.6) (559.0) (523.9) (438.2) (251.6) (128.1) (79) (142.1) (170.4) (93.8) (51.6) (26.2) 30.9
EPS (Diluted) 7.78 -4.73 -8.37 -7.79 -7.43 -6.64 -4.27 -2.75 -2.02 -4.17 -5.07 -2.97 -4.02 -1.11 0.00
Balance Sheet
Cash & Equivalents 984.6 779.7 594.0 279.8 189.7 208.8 288.0 227.6 191.2 231.7
Total Assets 2,911.2 1,705.0 1,895.7 1,705.6 1,938.1 2,208.3 1,623.8 1,119.2 391.7 269.3
Total Debt 492.3 2,471.1 2,229.1 1,461.5 1,269.4 420.4 328.0 153.0 145.0 98.2
Stockholders' Equity (205.3) (1,098.1) (818.6) (347.1) 1.4 482.0 594.3 350.7 156.4 119.6
Cash Flow
Operating Cash Flow 711.2 (107.7) (158.4) (356.7) (251.3) (194.1) (98.6) (27.6) (10.1) (103.6)
Capital Expenditure (8.9) (74.2) (120.6) (152.5) (85.3) (56.0) (45.4) (15.5) (3.1) (1.8)
Free Cash Flow 702.3 (181.9) (279.0) (509.1) (336.7) (250.0) (144.1) (43.2) (13.2) (105.3)